ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 83 filers reported holding ADAGIO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,860,650 | -8.5% | 1,094,500 | -43.5% | 0.00% | 0.0% |
| Q2 2023 | $2,032,669 | +110914.1% | 1,935,875 | +26.8% | 0.00% | 0.0% |
| Q1 2023 | $1,831 | +0.8% | 1,526,159 | +26.0% | 0.00% | 0.0% |
| Q4 2022 | $1,817 | -99.9% | 1,211,099 | +143.8% | 0.00% | 0.0% |
| Q3 2022 | $1,555,000 | +396.8% | 496,697 | +420.1% | 0.00% | – |
| Q2 2022 | $313,000 | -58.0% | 95,499 | -7.1% | 0.00% | – |
| Q4 2021 | $746,000 | +165.5% | 102,781 | +1447.7% | 0.00% | – |
| Q3 2021 | $281,000 | – | 6,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $15,722,025 | 18.03% |
| Alphabet Inc. | 5,680,785 | $9,657,334 | 0.62% |
| 683 Capital Management, LLC | 4,000,000 | $6,800,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $3,293,252 | 0.37% |
| Acuitas Investments, LLC | 208,579 | $354,584 | 0.21% |
| MAVERICK CAPITAL LTD | 5,270,290 | $8,959,493 | 0.20% |
| Orbimed Advisors | 5,270,400 | $8,959,680 | 0.19% |
| Slate Path Capital LP | 3,735,000 | $6,349,500 | 0.18% |
| Redmile Group, LLC | 1,440,725 | $2,449,233 | 0.12% |
| TANG CAPITAL MANAGEMENT LLC | 366,536 | $623,111 | 0.09% |